Ignite Creation Date:
2024-05-06 @ 2:04 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01966029
Status:
COMPLETED
Last Update Posted:
2019-09-26
First Post:
2013-09-10
Brief Title:
BMN 110 Phase 3B in Australian Patients
Sponsor:
Organization:
BioMarin Pharmaceutical